SCHEMBL7804607

SCHEMBL7804607

C=Cc1cc(C)ccc1C(C)C

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
TRPA1 O75762 1/20 0.50
CHRM1 P11229 1/20 0.50
SLC6A2 P23975 1/20 0.50
ADRA1A P35348 1/20 0.50
HTR2B P41595 1/20 0.50
TP53 P04637 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.38
ADRB2 P07550 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2A6 P11509 1/20 0.36
HSD17B10 Q99714 1/20 0.35
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32671492 1.00 LMNA (0.50) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL10896766 0.86 TP53 (0.41) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL8133333 0.79 LMNA (0.50) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL16958914 0.79 LMNA (0.55) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL449241 0.79 TYR (0.40) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL10338935 0.79 LMNA (0.50) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL29724084 0.79 LMNA (0.50) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL11263780 0.78 PTGS2 (0.42) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL16959712 0.78 RECQL (0.36) MEN1KMT2A
SCHEMBL16954304 0.78 GABRA1 (0.38) LMNATRPA1CHRM1SLC6A2ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0968159-B1 METHOD FOR PREPARATION OF STYRENES AVENTIS RES & TECH GMBH & CO (DE) 2001-10-10 EP claimed
US-6156948-A Method for preparation of styrenes AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) 2000-12-05 US claimed
US-11771089-B2 Large-scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness AGROFRESH INC. (US) 2023-10-03 US disclosed
US-20220361503-A1 LARGE-SCALE METHODS OF UNIFORMLY COATING PACKAGING SURFACES WITH A VOLATILE ANTIMICROBIAL TO PRESERVE FOOD FRESHNESS ALTER DOMUS US LLC 2022-11-17 US disclosed
EP-2900645-A1 3-PHENYLISOXAZOLIN DERIVATIVES WITH HERBICIDAL ACTION Bayer CropScience AG (DE) 2015-08-05 EP disclosed
EP-0968159-B1 METHOD FOR PREPARATION OF STYRENES AVENTIS RES & TECH GMBH & CO (DE) 2001-10-10 EP disclosed
US-6156948-A Method for preparation of styrenes AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) 2000-12-05 US disclosed
EP-0968159-A1 METHOD FOR PREPARATION OF STYRENES Aventis Research & Technologies GmbH & Co KG (DE) 2000-01-05 EP disclosed
WO-1998032719-A1 METHOD FOR PREPARATION OF STYRENES AVENTIS RESEARCH & TECHNOLOGY GMBH & CO KG (DE) 1998-07-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11771089-B2 Large-scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness TAS2R10, FOSB, TMBIM6 LMNA 701/4885TRPA1 629/4885CHRM1 3558/4885
US-20220361503-A1 LARGE-SCALE METHODS OF UNIFORMLY COATING PACKAGING SURFACES WITH A VOLATILE ANTIMICROBIAL TO PRESERVE FOOD FRESHNESS TAS2R10, FOSB, TMBIM6 LMNA 701/4885TRPA1 629/4885CHRM1 3558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.